Lorazepam challenge test: A unique clinical response in catatonia
- PMID: 34908697
- PMCID: PMC8611546
- DOI: 10.4103/0972-6748.328871
Lorazepam challenge test: A unique clinical response in catatonia
Abstract
Catatonia is a psychomotor behavioral syndrome characterized as a complex syndrome of bizarre motor behavior, impaired volition, and vegetative abnormalities. Catatonia is a medical emergency and if not recognized on time may have potentially fatal outcomes. We present a case series of three patients with catatonia, in whom Injection lorazepam 4 mg administered intravenously (Lorazepam Challenge) produced quick, optimum outcome.
Keywords: Bush Francis Catatonia Rating Scale; catatonia; clinical outcome; lorazepam challenge test.
Copyright: © 2021 Industrial Psychiatry Journal.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Johnson J. Catatonia: The tension insanity. Br J Psychiatry. 1993;162:733–8. - PubMed
-
- Northoff G. What catatonia can tell us about “top-down modulation”: A neuropsychiatric hypothesis. Behav Brain Sci. 2002;25:555–77. - PubMed
-
- van der Heijden FM, Tuinier S, Arts NJ, Hoogendoorn ML, Kahn RS, Verhoeven WM. Catatonia: Disappeared or under-diagnosed? Psychopathology. 2005;38:3–8. - PubMed
-
- Chalasani P, Healy D, Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med. 2005;35:1667–75. - PubMed
Publication types
LinkOut - more resources
Full Text Sources